Ziying Hu1, Minjie Chen2, Huifen Zhou3, Anui Tharakan4, Xiaoke Wang5, Lianglin Qiu6, Shuai Liang7, Xiaobo Qin8, Yuhao Zhang9, Wanjun Wang10, Yanyi Xu11, Zhekang Ying12. 1. Department of Endocrinology, The People's Hospital of Zhengzhou University (Henan Provincial People's Hospital), Zhengzhou, Henan 450003, China; Department of Medicine Cardiology Division, University of Maryland School of Medicine, Baltimore, MD 21201, USA. Electronic address: huziying828@126.com. 2. Department of Medicine Cardiology Division, University of Maryland School of Medicine, Baltimore, MD 21201, USA; Department of Environmental Health, School of Public Health, Fudan University, Shanghai 200032, China. Electronic address: MC9888@gmail.com. 3. Department of Medicine Cardiology Division, University of Maryland School of Medicine, Baltimore, MD 21201, USA; Department of Pathology, Hubei University of Science and Technology, Xianning, Hubei 437100, China. Electronic address: zhf_198019@163.com. 4. Department of Otolaryngology, John Hopkins University, Baltimore, MD 21205, USA. Electronic address: anuj.tharakan14@gmail.com. 5. Department of Medicine Cardiology Division, University of Maryland School of Medicine, Baltimore, MD 21201, USA; Department of Occupational and Environmental Health, School of Public Health, Nantong University, Nantong 226019, China. Electronic address: wxke111@hotmail.com. 6. Department of Medicine Cardiology Division, University of Maryland School of Medicine, Baltimore, MD 21201, USA; Department of Occupational and Environmental Health, School of Public Health, Nantong University, Nantong 226019, China. Electronic address: llqiu@ntu.edu.cn. 7. Department of Medicine Cardiology Division, University of Maryland School of Medicine, Baltimore, MD 21201, USA. Electronic address: doctorbach@163.com. 8. Department of Medicine Cardiology Division, University of Maryland School of Medicine, Baltimore, MD 21201, USA. Electronic address: xiaobo_qin0902@163.com. 9. Department of Neurology, Zhongshan Hospital, Fudan University, Shanghai 200032, China. Electronic address: xbtiger2002@163.com. 10. Department of Environmental Health, School of Public Health, Fudan University, Shanghai 200032, China. Electronic address: 16211020017@fudan.edu.cn. 11. Department of Environmental Health, School of Public Health, Fudan University, Shanghai 200032, China. Electronic address: yanyi_xu@fudan.edu.cn. 12. Department of Medicine Cardiology Division, University of Maryland School of Medicine, Baltimore, MD 21201, USA; Department of Environmental Health, School of Public Health, Fudan University, Shanghai 200032, China. Electronic address: yingzhekang@hotmail.com.
Abstract
BACKGROUND: Exposure to ambient fine particulate matter (PM2.5) is associated with increased cardiometabolic morbidity and mortality. This is widely believed to be attributable to PM2.5 exposure-induced pulmonary and subsequent systemic inflammation. Tumor necrosis factor alpha (TNFα), lymphotoxin α (LTα), and lymphotoxin β (LTβ) are three homologous pro-inflammatory cytokines, each with both unique and redundant activities in inflammation. Their role in PM2.5 exposure-induced inflammation and adverse cardiometabolic effects has to be determined. METHODS AND RESULTS: LTα/TNFα/LTβ triple-knockout (TNF/LT KO) and wildtype (WT) mice were exposed to concentrated ambient PM2.5 (CAP) for 5 months. Lung pathological analysis revealed that TNF/LT deficiency reduced CAP exposure-induced pulmonary inflammation. However, glucose homeostasis assessments showed that TNF/LT deficiency significantly aggravated CAP exposure-induced glucose intolerance and insulin resistance. Consistent with glucose homeostasis assessments, CAP exposure significantly increased the body weight and adiposity of TNF/LT KO but not WT mice. In contrast to its body weight effects, CAP exposure reduced food intake of WT but not TNF/LT KO mice. On the other hand, CAP exposure induced marked fat droplet accumulation in brown adipose tissues of WT mice and significantly decreased their uncoupling protein 1 (UCP1) expression, and these effects were markedly exacerbated in TNF/LT KO mice. CONCLUSION: The present study suggests that TNF/LT deficiency influences PM2.5 exposure-induced response of energy metabolism through alterations in both food intake and energy expenditure.
BACKGROUND: Exposure to ambient fine particulate matter (PM2.5) is associated with increased cardiometabolic morbidity and mortality. This is widely believed to be attributable to PM2.5 exposure-induced pulmonary and subsequent systemic inflammation. Tumor necrosis factor alpha (TNFα), lymphotoxin α (LTα), and lymphotoxin β (LTβ) are three homologous pro-inflammatory cytokines, each with both unique and redundant activities in inflammation. Their role in PM2.5 exposure-induced inflammation and adverse cardiometabolic effects has to be determined. METHODS AND RESULTS: LTα/TNFα/LTβ triple-knockout (TNF/LT KO) and wildtype (WT) mice were exposed to concentrated ambient PM2.5 (CAP) for 5 months. Lung pathological analysis revealed that TNF/LT deficiency reduced CAP exposure-induced pulmonary inflammation. However, glucose homeostasis assessments showed that TNF/LT deficiency significantly aggravated CAP exposure-induced glucose intolerance and insulin resistance. Consistent with glucose homeostasis assessments, CAP exposure significantly increased the body weight and adiposity of TNF/LT KO but not WT mice. In contrast to its body weight effects, CAP exposure reduced food intake of WT but not TNF/LT KOmice. On the other hand, CAP exposure induced marked fat droplet accumulation in brown adipose tissues of WT mice and significantly decreased their uncoupling protein 1 (UCP1) expression, and these effects were markedly exacerbated in TNF/LT KOmice. CONCLUSION: The present study suggests that TNF/LT deficiency influences PM2.5 exposure-induced response of energy metabolism through alterations in both food intake and energy expenditure.
Authors: Dmitry V Kuprash; Alexei V Tumanov; Dmitry J Liepinsh; Ekaterina P Koroleva; Marina S Drutskaya; Andrei A Kruglov; Alexander N Shakhov; Eileen Southon; William J Murphy; Lino Tessarollo; Sergei I Grivennikov; Sergei A Nedospasov Journal: Eur J Immunol Date: 2005-05 Impact factor: 5.532
Authors: Y Ohtsuka; K J Brunson; A E Jedlicka; W Mitzner; R W Clarke; L Y Zhang; S M Eleff; S R Kleeberger Journal: Am J Respir Cell Mol Biol Date: 2000-05 Impact factor: 6.914
Authors: Meredith C McCormack; Andrew J Belli; Deepak A Kaji; Elizabeth C Matsui; Emily P Brigham; Roger D Peng; Cortlandt Sellers; D'Ann L Williams; Gregory B Diette; Patrick N Breysse; Nadia N Hansel Journal: Eur Respir J Date: 2015-01-08 Impact factor: 16.671
Authors: Talita Romanatto; Maristela Cesquini; Maria E Amaral; Erika A Roman; Juliana C Moraes; Márcio A Torsoni; Ariovaldo P Cruz-Neto; Lício A Velloso Journal: Peptides Date: 2007-03-24 Impact factor: 3.750
Authors: Dmitry V Kuprash; Marat B Alimzhanov; Alexei V Tumanov; Sergei I Grivennikov; Alexander N Shakhov; Ludmila N Drutskaya; Michael W Marino; Regina L Turetskaya; Arthur O Anderson; Klaus Rajewsky; Klaus Pfeffer; Sergei A Nedospasov Journal: Mol Cell Biol Date: 2002-12 Impact factor: 4.272
Authors: A K Bauer; E L Travis; S S Malhotra; E A Rondini; C Walker; H-Y Cho; S Trivedi; W Gladwell; S Reddy; S R Kleeberger Journal: Eur Respir J Date: 2009-12-23 Impact factor: 16.671
Authors: Robert H Eckel; Steven E Kahn; Ele Ferrannini; Allison B Goldfine; David M Nathan; Michael W Schwartz; Robert J Smith; Steven R Smith Journal: Diabetes Care Date: 2011-05-20 Impact factor: 19.112